{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:34:55Z","timestamp":1764102895087,"version":"3.37.3"},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","award":["1U01FD005272"],"award-info":[{"award-number":["1U01FD005272"]}],"id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1111\/jcpt.12646","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T21:28:19Z","timestamp":1509571699000},"page":"327-335","source":"Crossref","is-referenced-by-count":12,"title":["Brand vs generic adverse event reporting patterns: An authorized generic-controlled evaluation of cardiovascular medications"],"prefix":"10.1155","volume":"43","author":[{"given":"Y.","family":"Alatawi","sequence":"first","affiliation":[{"name":"Department of Health Outcomes Research and Policy; Harrison School of Pharmacy; Auburn University; Auburn AL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. M.","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes Research and Policy; Harrison School of Pharmacy; Auburn University; Auburn AL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes Research and Policy; Harrison School of Pharmacy; Auburn University; Auburn AL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes Research and Policy; Harrison School of Pharmacy; Auburn University; Auburn AL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. L.","family":"Peissig","sequence":"additional","affiliation":[{"name":"Biomedical Informatics Research Center; Marshfield Clinic Research Foundation; Marshfield WI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. L.","family":"Berg","sequence":"additional","affiliation":[{"name":"Biomedical Informatics Research Center; Marshfield Clinic Research Foundation; Marshfield WI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. D.","family":"Page","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Medical Informatics and Computer Science; School of Medicine and Public Health; University of Wisconsin; Madison WI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes Research and Policy; Harrison School of Pharmacy; Auburn University; Auburn AL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"volume-title":"Adherence to Long-Term Therapies: Evidence for Action","year":"2003","author":"Sabat\u00e9","key":"10.1111\/jcpt.12646-BIB0001|jcpt12646-cit-0001"},{"key":"10.1111\/jcpt.12646-BIB0002|jcpt12646-cit-0002","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJMp1002305","article-title":"Thinking outside the pillbox-medication adherence as a priority for health care reform","volume":"362","author":"Cutler","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12646-BIB0003|jcpt12646-cit-0003","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/J058v17n01_06","article-title":"Consumer perceptions regarding generic drug substitution: an exploratory study","volume":"17","author":"Sansgiry","year":"2005","journal-title":"J Pharm Mark Manage"},{"key":"10.1111\/jcpt.12646-BIB0004|jcpt12646-cit-0004","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJMsa070502","article-title":"A decade of direct-to-consumer advertising of prescription drugs","volume":"357","author":"Donohue","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12646-BIB0005|jcpt12646-cit-0005","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11606-016-3612-7","article-title":"Variations in patients\u2019 perceptions and use of generic drugs: results of a national survey","volume":"31","author":"Kesselheim","year":"2016","journal-title":"J Gen Intern Med"},{"key":"10.1111\/jcpt.12646-BIB0006|jcpt12646-cit-0006","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/jamainternmed.2016.1688","article-title":"Prevalence and predictors of generic drug skepticism among physicians: results of a national survey","volume":"176","author":"Kesselheim","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1111\/jcpt.12646-BIB0007|jcpt12646-cit-0007","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/PSY.0b013e3182738826","article-title":"The effect of an apparent change to a branded or generic medication on drug effectiveness and side effects","volume":"75","author":"Faasse","year":"2013","journal-title":"Psychosom Med"},{"key":"10.1111\/jcpt.12646-BIB0008|jcpt12646-cit-0008","unstructured":"The Henry J. Kaiser Family Foundation Health insurance coverage of the total population http:\/\/kff.org\/other\/state-indicator\/total-population\/?state=al"},{"key":"10.1111\/jcpt.12646-BIB0009|jcpt12646-cit-0009","unstructured":"Commission FT Authorized generic drugs: short-term effects and long-term impact Retrieved September 2011 10 2014"},{"key":"10.1111\/jcpt.12646-BIB0010|jcpt12646-cit-0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5694\/mja16.00526","article-title":"Guideline for the diagnosis and management of hypertension in adults - 2016","volume":"205","author":"Gabb","year":"2016","journal-title":"Med J Aust"},{"issue":"25 Pt B","key":"10.1111\/jcpt.12646-BIB0011|jcpt12646-cit-0011","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jcpt.12646-BIB0012|jcpt12646-cit-0012","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1525-1497.2003.20130.x","article-title":"Adverse drug event monitoring at the Food and Drug Administration","volume":"18","author":"Ahmad","year":"2003","journal-title":"J Gen Intern Med"},{"key":"10.1111\/jcpt.12646-BIB0013|jcpt12646-cit-0013","unstructured":"FDA Questions and answers on FDA's Adverse Event Reporting System (FAERS) http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/"},{"key":"10.1111\/jcpt.12646-BIB0014|jcpt12646-cit-0014","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA Adverse Event Reporting System","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1111\/jcpt.12646-BIB0015|jcpt12646-cit-0015","unstructured":"Medical Dictionary for Regulatory Activities Standardised MedDRA queries http:\/\/www.meddra.org\/standardised-meddra-queries"},{"key":"10.1111\/jcpt.12646-BIB0016|jcpt12646-cit-0016","unstructured":"Medical Dictionary for Regulatory Activities MedDRA hierarchy http:\/\/www.meddra.org\/how-to-use\/basics\/hierarchy"},{"key":"10.1111\/jcpt.12646-BIB0017|jcpt12646-cit-0017","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/jcpt.12646-BIB0018|jcpt12646-cit-0018","doi-asserted-by":"crossref","first-page":"e1001802","DOI":"10.1371\/journal.pmed.1001802","article-title":"Paying physicians to prescribe generic drugs and follow-on biologics in the United States","volume":"12","author":"Sarpatwari","year":"2015","journal-title":"PLoS Med"},{"key":"10.1111\/jcpt.12646-BIB0019|jcpt12646-cit-0019","unstructured":"Barrett L Physicians\u2019 attitudes and practices regarding generic drugs"},{"key":"10.1111\/jcpt.12646-BIB0020|jcpt12646-cit-0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3111\/13696998.2013.873723","article-title":"Recent trends in brand-name and generic drug competition","volume":"17","author":"Grabowski","year":"2014","journal-title":"J Med Econ"},{"key":"10.1111\/jcpt.12646-BIB0021|jcpt12646-cit-0021","unstructured":"News DS Generic report 2016 http:\/\/www.drugstorenews.com\/sites\/drugstorenews.Com\/files\/GenericReport_2016.Pdf"},{"volume-title":"ISMP Quarter Watch: Monitoring FDA MedWatch Reports","year":"2015","author":"Moore","key":"10.1111\/jcpt.12646-BIB0022|jcpt12646-cit-0022"},{"key":"10.1111\/jcpt.12646-BIB0023|jcpt12646-cit-0023","unstructured":"Geetha ISPM Jodi BS Sonal S Identification of generic drugs in the FDA adverse event reporting system"},{"issue":"Suppl 1","key":"10.1111\/jcpt.12646-BIB0024|jcpt12646-cit-0024","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pds.2311","article-title":"The US Food and Drug Administration's sentinel initiative: expanding the horizons of medical product safety","volume":"21","author":"Robb","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12646","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12646\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:03:25Z","timestamp":1671818605000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12646","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"type":"print","value":"0269-4727"}],"subject":[],"published":{"date-parts":[[2017,11,1]]}}}